Abiopharma

GSI Technology to Participate in Needham Virtual Semiconductor & SemiCap Conference on August 19, 2026

Box Sets Date to Announce Second Quarter Fiscal 2027 Financial Results

Broadcom Inc. to Announce Third Quarter Fiscal Year 2026 Financial Results on Wednesday, September 2, 2026

Ginkgo Bioworks and Acies Bio Partner to Expand Global Access to High-Performance Aspergillus niger Strains for Protein Production

electroCore to Participate in Upcoming Investor Conferences

Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma

Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases

Letter to Surf Air Mobility Inc. Shareholders from Chairman of the Board

Griffon Corporation Announces Closing of AMES Australasia Transaction

Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial Results

VirTra Sets Second Quarter 2026 Conference Call for Thursday, August 13, 2026 at 4:30 p.m. ET

CrowdStrike Fal.Con 2026 Sells Out at Record Pace as the Industry Races to Secure AI

FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. difficile Infection

Hess Midstream LP Reports Estimated Results for the Second Quarter of 2026

Sonida Senior Living Announces Second Quarter Earnings Release Date and Conference Call